Cue Biopharma (CUE) Short Interest Ratio & Short Volume → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free CUE Stock Alerts $1.90 +0.06 (+3.26%) (As of 01:41 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Cue Biopharma Short Interest DataCurrent Short Volume4,120,000 sharesPrevious Short Volume3,970,000 sharesChange Vs. Previous Month+3.78%Dollar Volume Sold Short$8.53 millionShort Interest Ratio / Days to Cover14.7Last Record DateMarch 15, 2024Outstanding Shares45,120,000 sharesPercentage of Shares Shorted9.13%Today's Trading Volume128,277 sharesAverage Trading Volume261,554 sharesToday's Volume Vs. Average49% Short Selling Cue Biopharma ? Sign up to receive the latest short interest report for Cue Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCUE Short Interest Over TimeCUE Days to Cover Over TimeCUE Percentage of Float Shorted Over Time Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> Cue Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20244,120,000 shares $8.53 million +3.8%N/A14.7 $2.07 2/29/20243,970,000 shares $8.24 million +4.2%N/A12.7 $2.08 2/15/20243,810,000 shares $8.95 million +5.8%N/A10.8 $2.35 1/31/20243,600,000 shares $9.50 million -1.4%N/A10.6 $2.64 1/15/20243,650,000 shares $10.91 million +6.7%N/A10.1 $2.99 12/31/20233,420,000 shares $9.03 million +5.2%N/A9.4 $2.64 Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/15/20233,250,000 shares $9.20 million +8.3%N/A9.5 $2.83 11/30/20233,000,000 shares $7.50 million -1.0%N/A10 $2.50 11/15/20233,030,000 shares $7.21 million -2.6%N/A11.8 $2.38 10/31/20233,110,000 shares $6.53 million +19.6%N/A10.2 $2.10 10/15/20232,600,000 shares $5.33 million +2.4%N/A8.2 $2.05 9/30/20232,540,000 shares $5.84 million +2.8%N/A6.7 $2.30 9/15/20232,470,000 shares $6.32 million +1.2%N/A5.2 $2.56 8/31/20232,440,000 shares $6.61 million -20.3%N/A5 $2.71 8/15/20233,060,000 shares $8.60 million -5.9%N/A6.2 $2.81 7/31/20233,250,000 shares $12.42 million +30.0%N/A7.1 $3.82 7/15/20232,500,000 shares $11.13 million +28.2%N/A5.5 $4.45 6/30/20231,950,000 shares $7.12 million +142.2%N/A5.4 $3.65 6/15/2023805,200 shares $3.12 million +10.1%N/A2.5 $3.87 5/31/2023731,600 shares $2.93 million +36.2%N/A3 $4.00 5/15/2023537,100 shares $2.39 million +1.0%N/A2.4 $4.45 4/30/2023531,900 shares $2.30 million -21.6%N/A2.8 $4.33 4/15/2023678,200 shares $2.36 million -10.5%N/A4.8 $3.48 3/31/2023757,900 shares $2.71 million +35.4%N/A5.5 $3.57 3/15/2023559,600 shares $1.75 million +21.8%N/A4.4 $3.12 2/28/2023459,500 shares $1.29 million +4.9%N/A4.3 $2.80 2/15/2023438,000 shares $1.47 million -12.7%N/A3.9 $3.35 1/31/2023501,900 shares $1.72 million -22.1%N/A3.9 $3.42 1/15/2023644,500 shares $2.24 million +8.8%N/A5 $3.48 12/30/2022592,200 shares $1.69 million -17.4%N/A4.4 $2.85 12/15/2022717,000 shares $2.03 million -5.7%N/A4.4 $2.83 11/30/2022759,900 shares $2.93 million -12.9%N/A4.8 $3.86 11/15/2022872,100 shares $3.30 million -29.7%N/A5.4 $3.78 10/31/20221,240,000 shares $3.30 million -10.8%N/A7.6 $2.66 10/15/20221,390,000 shares $3.57 million -6.1%N/A8.2 $2.57 9/30/20221,480,000 shares $3.30 million -12.4%N/A8.2 $2.23 9/15/20221,690,000 shares $5.53 million -12.9%N/A6 $3.27 8/31/20221,940,000 shares $5.70 million No ChangeN/A6.1 $2.94 8/15/20221,940,000 shares $6.48 million -11.0%N/A5.5 $3.34 7/31/20222,180,000 shares $5.93 million -0.5%N/A5.5 $2.72Only a fool would buy Nvidia today… (Ad)Average people are too busy throwing their money into Nvidia, Google, and every other overvalued tech firm… while missing what could be the biggest story of the decade.In this new presentation – which Porter Stansberry details why this company could be the linchpin of CUE Short Interest - Frequently Asked Questions What is Cue Biopharma's current short interest? Short interest is the volume of Cue Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 4,120,000 shares of CUE short. Learn More on Cue Biopharma's current short interest. What is a good short interest ratio for Cue Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CUE shares currently have a short interest ratio of 15.0. Learn More on Cue Biopharma's short interest ratio. Which institutional investors are shorting Cue Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cue Biopharma: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cue Biopharma's short interest increasing or decreasing? Cue Biopharma saw a increase in short interest in March. As of March 15th, there was short interest totaling 4,120,000 shares, an increase of 3.8% from the previous total of 3,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cue Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cue Biopharma: Vaxxinity, Inc. (8.50%), Aclaris Therapeutics, Inc. (7.22%), Tempest Therapeutics, Inc. (4.16%), Veru Inc. (6.90%), Rezolute, Inc. (0.54%), PMV Pharmaceuticals, Inc. (5.56%), LifeVantage Co. (0.80%), Affimed (1.32%), BioXcel Therapeutics, Inc. (14.63%), Chimerix, Inc. (1.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Cue Biopharma stock? Short selling CUE is an investing strategy that aims to generate trading profit from Cue Biopharma as its price is falling. CUE shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cue Biopharma? A short squeeze for Cue Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CUE, which in turn drives the price of the stock up even further. How often is Cue Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUE, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VAXX Short Squeeze ACRS Short Squeeze TPST Short Squeeze VERU Short Squeeze RZLT Short Squeeze PMVP Short Squeeze LFVN Short Squeeze AFMD Short Squeeze BTAI Short Squeeze CMRX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CUE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceFed launches fourth dollar overhaulStansberry Research“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings